SCHEDULE: FMR LLC Discloses 9.7% Stake in QuidelOrtho Corp

FMR LLC, along with Abigail P. Johnson, has filed a Schedule 13G, reporting beneficial ownership of 9.7% of QuidelOrtho Corp's common stock as of March 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, indicating their beneficial ownership of QuidelOrtho Corp's common stock.
• The filing, dated March 31, 2026, reports a total of 6,591,151.54 shares, representing 9.7% of the class.
• FMR LLC holds sole voting power over 6,587,889 shares and sole dispositive power over 6,591,151.54 shares.
• Abigail P. Johnson is identified as a Director, Chairman, and CEO of FMR LLC.
• The filing clarifies that while members of the Johnson family are predominant owners of FMR LLC, no single person's interest in QuidelOrtho Corp's common stock exceeds five percent.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain performance data or strategic announcements.

Positives

• Significant institutional ownership by FMR LLC, suggesting confidence in QuidelOrtho Corp's long-term prospects.
• Clear disclosure of beneficial ownership, providing transparency to the market.

Risks

• The filing does not detail specific risks associated with the investment, as it is a Schedule 13G focused on ownership disclosure.

Future Outlook

This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance regarding QuidelOrtho Corp's future performance.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that significant ownership filings like this Schedule 13G from major investment firms such as FMR LLC often signal substantial institutional interest and can influence market perception of a company's stability and growth potential within the healthcare diagnostics sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional ownership, potentially influencing investor confidence.
• Management: The filing confirms FMR LLC's investment is in the ordinary course of business, not for control.
• Regulators: Compliance with SEC reporting requirements for significant beneficial ownership.

Key Dates

Keywords

QuidelOrtho Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management